Seeking Alpha

XLRN
  Acceleron Pharma Inc. - NASDAQ

8/20/2014, 3:16 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
XLRN vs. ETF Alternatives
Company Description
Acceleron Pharma Inc discovers, develops, and commercializes novel protein therapeutics for novel protein therapeutics for cancer and rare diseases. Its primary product is the biology of the Transforming Growth Factor-Beta protein superfamily.